Keyphrases
COVID-19
100%
Comorbidity
62%
Spain
43%
Population Cohort Study
41%
Multinational Network
41%
South Korea
36%
Hospitalization
36%
International Networks
35%
External Validation
34%
Older People
33%
COVID-19 Patients
33%
Cardiovascular Risk Prediction
31%
Performance Prediction
31%
Risk Prediction Tool
31%
Competing Risks
28%
United States
26%
Hydroxychloroquine
26%
QRISK3
25%
Competing Mortality Risk
22%
Health Condition
21%
Asthma
21%
Influenza
21%
Prediction Tool
20%
QFracture
20%
Controlled Interrupted Time Series Analysis
20%
United States South
20%
UK Population
20%
Angiotensin-converting Enzyme Inhibitor (ACEi)
20%
South Europe
20%
Odds Ratio
20%
Thrombocytopenia
20%
Population-based Cohort Study
20%
Population-based
20%
Sectional Analysis
20%
Scotland
20%
COVID-19 Outcomes
18%
Pneumonia
17%
Primary Care
17%
COVID-19 Pandemic
15%
Validation Cohort
15%
Hip Fracture
15%
Osteoporotic Fractures
15%
Risk Model
15%
Cardiovascular Disease
14%
Obesity
14%
Chronic Obstructive Pulmonary Disease
14%
Interrupted Time Series Regression
14%
Rheumatoid Arthritis
14%
Patients with COVID-19
14%
Azithromycin
13%
Whole Population
13%
Hazard Ratio
13%
Hospitalized Patients
13%
Time Series Regression Analysis
13%
Hypertension
12%
Acute Kidney Injury
12%
Clinical Practice Research Datalink
12%
United Kingdom
12%
Background Rates
11%
High Risk
11%
Hospital Admission
11%
Drug Repurposing
11%
Healthcare Data
11%
Atrial Fibrillation
11%
Cancer History
11%
Angiotensin Receptor Blockers
10%
C-statistic
10%
Diabetes
10%
Thrombosis with Thrombocytopenia Syndrome
10%
COVID-19 Vaccine Safety
10%
Fracture Prediction
10%
Vaccine-induced Immune Thrombotic Thrombocytopenia
10%
Drug Use in Pregnancy
10%
Validation Population
10%
External Validation Study
10%
COVID-19 Vulnerability Index
10%
Label Change
10%
Diclofenac
10%
Deprivation
10%
Quality Indicators
10%
International Cohort
10%
Intolerance
10%
Psychosis
10%
Sweden
10%
Peer Review
10%
Opioid Prescribing
10%
Methodological Considerations
10%
Thrombosis
10%
AIDS/HIV
10%
Norway
10%
National Clinical Guidelines
10%
Renin-angiotensin System Blockers
10%
Depression Risk
10%
Meta-analysis
10%
Antithyroid Drugs
10%
Open Science
10%
Vaccine Evaluation
10%
α1-blocker
10%
Chronic Obstructive Pulmonary Disease Patient
10%
European Countries
10%
People Living with HIV (PLHIV)
10%
Systematic Meta-analysis
10%
Individualized Prediction
10%
Network Studies
10%
Outpatient Visits
10%
Adult Mental Health
10%
Deep Phenotyping
10%
Lifetime Risk
10%
Population-based Cross-sectional Study
10%
Risk Calculator
10%
Risk Estimation
10%
Benign Prostatic Hyperplasia
10%
International Experience
10%
Suicidal Ideation
10%
Disease Outcome
10%
Suicide Risk
10%
Dispensed Medications
10%
Patient Profile
10%
Primary Care Population
10%
Selected Indicators
10%
Cohort Analysis
10%
Adult Patients
10%
Phenotype Algorithms
10%
Disease Pattern
10%
Adjuvant Therapy
10%
Interrupted Time Series
10%
Living with
10%
Rheumatoid Arthritis Treatment
10%
Autoimmune Disease
10%
Health-related
10%
Chronic Pain
10%
Financial Incentives
10%
Patient Outcomes
10%
Quality of Care
10%
Birth Defects
10%
China
10%
Clinical High Risk for Psychosis (CHR-P)
10%
Netherlands
8%
Suicide
8%
Age Groups
8%
Monotherapy
8%
Propylthiouracil
7%
Cardiovascular Risk
7%
Prediction Model
7%
Confidence Interval
6%
Antidepressants
6%
Depressed Mood
6%
Slope Change
6%
Electronic Health Records
6%
Electronic Medical Records
6%
British Thoracic Society
6%
Metaanalysis
6%
Peripheral Arterial Disease
6%
Thiazides
6%
Heart Disease
6%
Medication Use
6%
Cardiovascular Mortality
6%
Risk Ratio
5%
Risk-adjusted
5%
Hyperthyroidism
5%
Incident Cardiovascular Disease
5%
Cardiovascular Disease Events
5%
Germany
5%
Acute Respiratory Distress Syndrome
5%
Optum
5%
New User
5%
10-year Risk
5%
Thrombocytopenia Syndrome
5%
Delusional Disorder
5%
Ischemic Heart Disease
5%
Gabapentinoids
5%
Psychostimulants
5%
Schizophrenia
5%
Vaccine Response
5%
Mood Disorders
5%
Calcium Channel Blockers
5%
Mental Health
5%
Corticosteroids
5%
Sedative-hypnotic
5%
Europe
5%
Medicine and Dentistry
Cohort Analysis
95%
COVID-19
87%
Comorbidity
47%
Cohort Effect
32%
Cross Sectional Study
31%
Primary Health Care
30%
Cardiovascular Risk
20%
Hip Fracture
20%
Fragility Fracture
20%
Thrombosis
20%
Human Immunodeficiency Virus
20%
Odds Ratio
20%
Cardiovascular Disease
20%
Thrombocytopenia
20%
Hazard Ratio
15%
Malignant Neoplasm
14%
Prevalence
13%
Outpatient
13%
Mental Health
12%
Nephropathy
12%
Acute Kidney Injury
12%
Clinical Guideline
11%
Health Care
11%
Rheumatoid Arthritis
11%
Inflammatory Arthritis
11%
Atrial Fibrillation
11%
Prostate Hypertrophy
10%
Lifespan
10%
Thrombotic Thrombocytopenic Purpura
10%
Alpha 1 Adrenergic Receptor Blocking Agent
10%
COVID-19 Vaccine
10%
Hydroxychloroquine
10%
Chronic Pain
10%
Ischemic Heart Disease
10%
Gabapentinoid
10%
ACE Inhibitor
10%
Renin Angiotensin Aldosterone System
10%
Time Series Analysis
9%
Angiotensin Receptor Antagonist
8%
Monotherapy
8%
General Medicine
7%
Delusional Disorder
6%
Psychostimulant
6%
Hypnotic Sedative Agent
6%
Mood Disorder
6%
Antidepressant
6%
Diabetes
6%
Thiazide Diuretic Agent
6%
Anticoagulant Therapy
6%
Electronic Patient Record
5%
Electronic Health Record
5%
Pressure Control
5%
Antiplatelet
5%
Blood Pressure
5%
Apoplexy
5%
Arteriosclerosis Obliterans
5%
Transient Ischemic Attack
5%
Care Planning
5%
Hemoglobin A1c
5%
Influenza Vaccination
5%
Mental Health Care
5%
Glycated Hemoglobin
5%
Diuretics
5%
Calcium Channel Blocking Agent
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
76%
Diseases
45%
Coronavirinae
31%
Comorbidity
25%
Dipeptidyl Carboxypeptidase Inhibitor
20%
Asthma
20%
Thrombosis
20%
Fragility Fracture
20%
Hip Fracture
20%
Hydroxychloroquine
20%
Thrombocytopenia
20%
Azithromycin
17%
Chronic Obstructive Lung Disease
14%
Kidney Disease
14%
Acute Kidney Failure
13%
Cardiovascular Disease
12%
Prevalence
11%
Observational Study
11%
Angiotensin Receptor Antagonist
10%
Retrospective Study
10%
Flu Like Syndrome
10%
Thrombotic Thrombocytopenic Purpura
10%
Alpha 1 Adrenergic Receptor Blocking Agent
10%
Angiotensin
10%
Renin
10%
SARS Coronavirus
10%
Rheumatoid Arthritis
10%
Diclofenac
10%
Autoimmune Disease
10%
Prostate Hypertrophy
10%
Syndrome
10%
Antidepressant
10%
Chronic Pain
10%
COVID-19 Vaccine
10%
Inflammatory Arthritis
10%
Antithyroid Agent
10%
Gabapentinoid
10%
Congenital Malformation
10%
Monotherapy
8%
Delusional Disorder
7%
Psychostimulant
7%
Hypnotic Sedative Agent
7%
Mood Disorder
7%
Umifenovir
6%
Pandemic
6%
Propylthiouracil
6%
Anticoagulant Agent
6%
Thiazide Diuretic Agent
6%
Adult Respiratory Distress Syndrome
5%
Malignant Neoplasm
5%
Hyperlipidemia
5%
Heart Disease
5%
Fatality
5%
Ischemic Heart Disease
5%
Calcium Channel Blocker
5%
Peripheral Occlusive Artery Disease
5%
Anxiety Disorder
5%
Diuretics
5%
Analgesic Agent
5%
Hyperthyroidism
5%